No causal relationship between glucose and inflammatory bowel disease: a bidirectional two-sample mendelian...

Area of Science:

• Genetics
• Gastroenterology
• Metabolic disorders

Background:

• Observational studies suggest a link between glucose levels and inflammatory bowel disease (IBD).
• Causality between elevated glucose and IBD, Crohn's disease (CD), and ulcerative colitis (UC) remains unclear.
• This study investigates the potential causal relationship using genetic data.

Purpose of the Study:

• To determine if genetically predicted elevated glucose causally influences the risk of developing IBD.
• To investigate the causal relationship between glucose and subtypes of IBD: CD and UC.
• To examine the potential causal effect of IBD and its subtypes on glucose metabolism and related traits.

Main Methods:

• A two-sample Mendelian Randomization (MR) approach was employed.
• Utilized large-scale genome-wide association study (GWAS) data for IBD, CD, UC, glucose, HbA1c, and type 2 diabetes (T2DM).
• Employed inverse-variance weighted (IVW) method and various sensitivity analyses to ensure result robustness.

Main Results:

• No evidence of a causal effect of genetically predicted glucose on overall IBD.
• Suggestive, but not statistically significant, association between glucose and Crohn's disease.
• No significant causal association found between glucose and ulcerative colitis.
• No evidence for a causal relationship in the reverse direction: IBD and its subtypes do not appear to influence glucose levels or related glycemic traits.

Conclusions:

• This MR study does not support a causal relationship between elevated glucose and IBD (including CD and UC).
• No causal association was found in the reverse direction, with IBD not influencing glucose metabolism.
• Further research with stronger genetic instruments is recommended to confirm these findings.